Anaplastic large-cell lymphoma (ALCL) is a T cell Non-Hodgkin Lymphoma (NHL) which accounts for 10–15% of paediatric/adolescent cases [1], and which can be separated into two distinct subclasses based on differential expression of anaplastic lymphoma kinase (ALK). This evidence concerns the gene ALK and T-cell non-Hodgkin lymphoma.